442 related articles for article (PubMed ID: 15790913)
1. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
2. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
4. Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina.
Mizuno S; Nishiwaki A; Morita H; Miyake T; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2831-6. PubMed ID: 17525219
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression.
Wang K; Wang Y; Gao L; Li X; Li M; Guo J
Biol Pharm Bull; 2008 Aug; 31(8):1541-6. PubMed ID: 18670086
[TBL] [Abstract][Full Text] [Related]
6. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
7. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
11. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
13. PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats.
Nonaka A; Kiryu J; Tsujikawa A; Yamashiro K; Miyamoto K; Nishiwaki H; Honda Y; Ogura Y
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2702-6. PubMed ID: 10937586
[TBL] [Abstract][Full Text] [Related]
14. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
16. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
17. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
[TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
[TBL] [Abstract][Full Text] [Related]
20. Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide.
Kinoshita N; Kakehashi A; Inoda S; Itou Y; Kuroki M; Yasu T; Kawakami M; Kanazawa Y
Diabetologia; 2002 May; 45(5):735-9. PubMed ID: 12107755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
